Common genes responsive to TGF-β in MeT-5A and Y-MESO-27 cells
| Symbol | Description |
| MeT-5A and Y-MESO-27 common genes up (>1.5fold) | |
| CSF1R | colony-stimulating factor 1 receptor |
| SNAI1 | snail homologue 1 |
| LOX* | lysyl oxidase |
| RASGRP1 | RAS guanyl-releasing protein 1 |
| MMP2* | matrix metallopeptidase 2 |
| ITGA11* | integrin, alpha 11 |
| SERPINE1 | plasminogen activator inhibitor type 1 |
| BMP6 | bone morphogenetic protein 6 |
| GDF6 | growth differentiation factor 6 |
| COL1A1* | Prepro-alpha1(I) collagen |
| EDN1 | endothelin 1 |
| COL1A2* | collagen, type I, alpha 2 |
| MFAP4 | microfibrillar-associated protein 4 |
| SERPINE2 | plasminogen activator inhibitor type 1, member 2 |
| COL20A1* | collagen, type XX, alpha 1 |
| COL5A1* | collagen, type V, alpha 1 |
| ITGB3* | integrin, beta 3 |
| LTBP2 | latent transforming growth factor beta binding protein 2 |
| SMAD7 | SMAD family member 7 |
| COL7A1* | collagen, type VII, alpha 1 |
| SKIL | SKI-like oncogene |
| COL4A1* | collagen, type IV, alpha 1 |
| TGFB1 | transforming growth factor, beta 1 |
| ITGAV* | integrin, alpha V (vitronectin receptor) |
| IGFBP3 | insulin-like growth factor binding protein 3 |
| COL4A4* | collagen, type IV, alpha 4 |
| CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) |
| GADD45B | growth arrest and DNA-damage-inducible, beta |
| ADAM12 | ADAM metallopeptidase domain 12 |
| BMPR2 | bone morphogenetic protein receptor, type II |
| ITGA1* | integrin, alpha 1 |
| COL16A1* | collagen, type XVI, alpha 1 |
| MDAC1 | MDAC1 |
| TGFB2 | transforming growth factor, beta 2 |
| EGR2 | early growth response 2 |
| CTGF* | connective tissue growth factor |
| ID3 | inhibitor of DNA binding 3 |
| FN1* | fibronectin |
| MeT-5A and Y-MESO-27 common genes down (<0.67-fold) | |
| IL6R | interleukin 6 receptor |
| VCAM1 | vascular cell adhesion molecule 1 |
| CASP1 | caspase 1, apoptosis-related cysteine peptidase |
| IL12A | interleukin 12, alpha |
| IL1A | interleukin 1, alpha |
| IL7 | interleukin 7 |
| FAS | TNF receptor superfamily, member 6 |
| MMP26* | matrix metallopeptidase 26 |
| FGF23 | fibroblast growth factor 23 |
| CAMK2A | calcium/calmodulin-dependent protein kinase II alpha |
| NEDD4L | neural precursor cell expressed, developmentally down regulated 4-like |
| COL24A1* | collagen, type XXIV, alpha 1 |
| TGFA | transforming growth factor, alpha |
| CAMK2D | calcium/calmodulin-dependent protein kinase II delta |
| TLR3 | toll-like receptor 3 |
| BCL2 | B-cell CLL/lymphoma 2 |
| Symbol | Description |
| MeT-5A and Y-MESO-27 common genes up (>1.5fold) | |
| CSF1R | colony-stimulating factor 1 receptor |
| SNAI1 | snail homologue 1 |
| LOX* | lysyl oxidase |
| RASGRP1 | RAS guanyl-releasing protein 1 |
| MMP2* | matrix metallopeptidase 2 |
| ITGA11* | integrin, alpha 11 |
| SERPINE1 | plasminogen activator inhibitor type 1 |
| BMP6 | bone morphogenetic protein 6 |
| GDF6 | growth differentiation factor 6 |
| COL1A1* | Prepro-alpha1(I) collagen |
| EDN1 | endothelin 1 |
| COL1A2* | collagen, type I, alpha 2 |
| MFAP4 | microfibrillar-associated protein 4 |
| SERPINE2 | plasminogen activator inhibitor type 1, member 2 |
| COL20A1* | collagen, type XX, alpha 1 |
| COL5A1* | collagen, type V, alpha 1 |
| ITGB3* | integrin, beta 3 |
| LTBP2 | latent transforming growth factor beta binding protein 2 |
| SMAD7 | SMAD family member 7 |
| COL7A1* | collagen, type VII, alpha 1 |
| SKIL | SKI-like oncogene |
| COL4A1* | collagen, type IV, alpha 1 |
| TGFB1 | transforming growth factor, beta 1 |
| ITGAV* | integrin, alpha V (vitronectin receptor) |
| IGFBP3 | insulin-like growth factor binding protein 3 |
| COL4A4* | collagen, type IV, alpha 4 |
| CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) |
| GADD45B | growth arrest and DNA-damage-inducible, beta |
| ADAM12 | ADAM metallopeptidase domain 12 |
| BMPR2 | bone morphogenetic protein receptor, type II |
| ITGA1* | integrin, alpha 1 |
| COL16A1* | collagen, type XVI, alpha 1 |
| MDAC1 | MDAC1 |
| TGFB2 | transforming growth factor, beta 2 |
| EGR2 | early growth response 2 |
| CTGF* | connective tissue growth factor |
| ID3 | inhibitor of DNA binding 3 |
| FN1* | fibronectin |
| MeT-5A and Y-MESO-27 common genes down (<0.67-fold) | |
| IL6R | interleukin 6 receptor |
| VCAM1 | vascular cell adhesion molecule 1 |
| CASP1 | caspase 1, apoptosis-related cysteine peptidase |
| IL12A | interleukin 12, alpha |
| IL1A | interleukin 1, alpha |
| IL7 | interleukin 7 |
| FAS | TNF receptor superfamily, member 6 |
| MMP26* | matrix metallopeptidase 26 |
| FGF23 | fibroblast growth factor 23 |
| CAMK2A | calcium/calmodulin-dependent protein kinase II alpha |
| NEDD4L | neural precursor cell expressed, developmentally down regulated 4-like |
| COL24A1* | collagen, type XXIV, alpha 1 |
| TGFA | transforming growth factor, alpha |
| CAMK2D | calcium/calmodulin-dependent protein kinase II delta |
| TLR3 | toll-like receptor 3 |
| BCL2 | B-cell CLL/lymphoma 2 |
MeT-5A and Y-MESO-27 cells were treated with TGF-β for 24 h. Total RNA was extracted and subjected to microarray analysis. The genes encoding ECM-related protein are indicated by an asterisk.